The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Predictive Technology Group's Revenue for the
three
months ended in Mar. 2021 was $6.89 Mil. Predictive Technology Group's average Accounts Receivable for the
three
months ended in Mar. 2021 was $1.37 Mil.
Hence, Predictive Technology Group's Receivables Turnover for the
three
months ended in Mar. 2021 was 5.04.
Predictive Technology Group (OTCPK:PREDQ) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Predictive Technology Group Receivables Turnover Related Terms
Predictive Technology Group Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predictive Technology Group Receivables Turnover Chart
PREDQ vs GLMD, RCAR, CKPT: Receivables Turnover Comparison
For the Biotechnology subindustry, Predictive Technology Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Predictive Technology Group Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Predictive Technology Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Predictive Technology Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predictive Technology Group (PREDQ) has a Receivables Turnover of 5.04 as of Mar. 2021. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Predictive Technology Group and its competitors.
Is Predictive Technology Group's Receivables Turnover too high?
Predictive Technology Group's current Receivables Turnover is 5.04. The Biotechnology industry median Receivables Turnover is 5.30. Predictive Technology Group's value of 5.04 is 4.9% below this industry median.
How does Predictive Technology Group's Receivables Turnover compare to GLMD and RCAR?
Predictive Technology Group's Receivables Turnover of 5.04 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.30. Predictive Technology Group's value of 5.04 is 4.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.30, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Predictive Technology Group's current Receivables Turnover of 5.04 is 4.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Predictive Technology Group and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Predictive Technology Group's current Receivables Turnover is 5.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predictive Technology Group stock overvalued right now?
Predictive Technology Group (PREDQ) has a current Receivables Turnover of 5.04. The current Receivables Turnover is 5.04 and 4.9% below the Biotechnology industry median of 5.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Predictive Technology Group (PREDQ), the current Receivables Turnover is 5.04 as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PREDQ has been successfully added to your 